{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:41:39Z","timestamp":1648669299250},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jgyn.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T07:15:15Z","timestamp":1475306115000},"page":"1091-1098","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Le statut hyperandrog\u00e9nique, dans le syndrome des ovaires polykystiques, est t-il une entrave \u00e0 la r\u00e9ussite de la f\u00e9condation in vitro\u00a0?"],"prefix":"10.1016","volume":"45","author":[{"given":"M.","family":"Gaddas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chaouache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ajina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Tabka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zaouali Ajina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2016.08.007_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","article-title":"Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies","volume":"30","author":"Lujan","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09513590802582644","article-title":"Testosterone and dehydroepiandrosterone sulphate levels and IVF\/ICSI results","volume":"25","author":"Hossein Rashidi","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0015","first-page":"291","article-title":"Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology","volume":"8","author":"Costello","year":"2012","journal-title":"Womens Health"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/humrep\/dep378","article-title":"Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal\/stimulated steroid levels","volume":"25","author":"Hugues","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09513590.2011.613965","article-title":"The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia","volume":"28","author":"Misichronis","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7827-9-9","article-title":"Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome","volume":"9","author":"Qin","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0035","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1210\/jc.2009-2717","article-title":"Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?","volume":"95","author":"Burgers","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5114\/aoms.2012.28563","article-title":"Insulin resistance in women with hirsutism","volume":"8","author":"Cebeci","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0055","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/humrep\/dep121","article-title":"Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype","volume":"24","author":"Rizzo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1477-7827-9-116","article-title":"The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0065","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/14.2.354","article-title":"Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients","volume":"14","author":"Ludwing","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humrep\/dep393","article-title":"Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF","volume":"25","author":"Dickerson","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/molehr\/gap006","article-title":"Androgen receptor's destiny in mammalian oocytes: a new hypothesis","volume":"15","author":"Li","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0085","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/REP-10-0094","article-title":"Theca: the forgotten cell of the ovarian follicle","volume":"140","author":"Young","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0095","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.rbmo.2009.09.012","article-title":"Role of androgens in the treatment of patients with low ovarian response","volume":"19","author":"Laufer","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0100","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.fertnstert.2011.04.083","article-title":"Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment","volume":"95","author":"Sunkara","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0105","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/endo.141.12.7816","article-title":"High Insulin-Like Growth Factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1\u00a0receptor","volume":"141","author":"Chi","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jgyn.2008.12.001","article-title":"Qualit\u00e9 ovocytaire et embryonnaire et issue des cycles d\u2019ICSI chez les patientes porteuses d\u2019un syndrome des ovaires polykystiques (SOPK) versus normo-ovulantes","volume":"38","author":"Kdous","year":"2009","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2016.08.007_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/REP-10-0336","article-title":"Increased apoptosis in bovine blastocysts exposed to high levels of IGF1\u00a0is not associated with down regulation of the IGF1\u00a0receptor","volume":"141","author":"Velazquez","year":"2011","journal-title":"Reproduction"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516300916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231516300916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T05:33:40Z","timestamp":1568439220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231516300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0368231516300916"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.08.007","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le statut hyperandrog\u00e9nique, dans le syndrome des ovaires polykystiques, est t-il une entrave \u00e0 la r\u00e9ussite de la f\u00e9condation in vitro\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}